Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: A hypoxia-specific and mitochondria-targeted anticancer theranostic agent with high selectivity for cancer cells
Mingxing
Hu
a,
Chao
Yang
a,
Yi
Luo
a,
Fan
Chen
a,
Fangfang
Yang
a,
Shuping
Yang
a,
Hao
Chen
a,
Zhiqiang
Cheng
b,
Kun
Li
ac and
Yongmei
Xie
*a
aState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan Province 610041, P. R. China. E-mail: xieym@scu.edu.cn
bDepartment of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
cKey Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry Sichuan University, 29, Wangjiang Road, Chengdu, Sichuan Province 610064, P. R. China
First published on 26th June 2018
Abstract
Correction for ‘A hypoxia-specific and mitochondria-targeted anticancer theranostic agent with high selectivity for cancer cells’ by Mingxing Hu et al., J. Mater. Chem. B, 2018, 6, 2413–2416.
The authors wish to point out an error in Fig. 3d of the published article where the word “β-action” should read “β-actin”. The corrected version of Fig. 3 is shown below (note that the figure caption remains unchanged).
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2018 |